Stay updated on Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial

Sign up to get notified when there's something new on the Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T03:28:00.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Footer Revision updated from v3.4.2 to v3.4.3; no changes to study content or data.
    Difference
    0.1%
    Check dated 2026-03-11T20:07:24.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Addition of Revision: v3.4.2 and removal of the government funding status notice appear to be site housekeeping; no changes to the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T05:43:33.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Added a site-wide government funding status notice and updated the site revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.5%
    Check dated 2026-02-04T05:39:20.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Show glossary added; the QC criteria label text and capitalization changed (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and a site revision indicator shows 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T03:14:23.000Z thumbnail image
  9. Check
    88 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.3.4, replacing the previous v3.3.3; this change does not affect the study details or any user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:01:08.000Z thumbnail image

Stay in the know with updates to Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial page.